[go: up one dir, main page]

WO2025027033A1 - Composition de soin sans silicone pour matières kératiniques - Google Patents

Composition de soin sans silicone pour matières kératiniques Download PDF

Info

Publication number
WO2025027033A1
WO2025027033A1 PCT/EP2024/071577 EP2024071577W WO2025027033A1 WO 2025027033 A1 WO2025027033 A1 WO 2025027033A1 EP 2024071577 W EP2024071577 W EP 2024071577W WO 2025027033 A1 WO2025027033 A1 WO 2025027033A1
Authority
WO
WIPO (PCT)
Prior art keywords
weight
composition
composition according
respect
silicone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
PCT/EP2024/071577
Other languages
English (en)
Inventor
Jennifer LAVALEE
Romain ROUMIGUIERE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Publication of WO2025027033A1 publication Critical patent/WO2025027033A1/fr
Anticipated expiration legal-status Critical
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
    • A61K8/8182—Copolymers of vinyl-pyrrolidones. Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30—Characterized by the absence of a particular group of ingredients
    • A61K2800/34—Free of silicones

Definitions

  • the present invention relates to a composition, preferably cosmetic, comprising in a physiologically acceptable aqueous medium: a) hydrogenated lecithin, b) at least one thickener chosen from acrylic polymers and acrylamide polymers, c) lauroyl lysine or one of its salts, and d) isopropyl isostearate, said composition being substantially free from silicone.
  • the present invention relates to a composition, preferably cosmetic, comprising in a physiologically acceptable medium: a) hydrogenated lecithin, b) at least one thickener chosen from acrylic polymers and acrylamide polymers, c) lauroyl lysine or one of its salts, and d) isopropyl isostearate, said composition being substantially free from silicone.
  • compositions further comprise sustainable ingredients, helping to meet environmental challenges.
  • “Physiologically acceptable” means a medium compatible with keratin materials.
  • Substantially free from silicone means that the composition comprises less than 1% by weight with respect to the total weight of the composition, preferably less than 0.5% by weight, preferably less than 0.3% by weight, preferably less than 0.1% by weight, more preferably from 0.01 % to 1 % by weight of silicone. Preferably, the composition is totally free from silicone. Silicone means any silicone compound.
  • the composition according to the invention is in the form of an emulsion, preferably an oil-in-water emulsion.
  • Lecithin comprises essentially phosphatidylcholines, molecules composed of a choline residue, a phosphate group, a glycerol residue and two C14-C24 fatty acid residues, generally different from each other.
  • lecithin that may be used in the present invention does not necessarily have to be pure phosphatidylcholine, but may contain other phospholipids such as phosphatidyl ethanolamine, phosphatidyl serine, phosphatidyl inositol, as well as egg yolk, soybean, corn or rapeseed neutral fats.
  • lecithin refers to the overall composition which may contain other phospholipids and neutral fats in addition to phosphatidylcholine.
  • the hydrogenated lecithins that may be used in the present invention are: (1 ) hydrogenated synthetic lecithin; and (2) hydrogenated natural lecithin obtained by extracting lecithin from egg yolk, soybean, corn and rapeseed oil followed by a hydrogenation.
  • the iodine value of the hydrogenated lecithin must be less than 10.
  • a hydrogenated lecithin suitable for the invention is for example marketed by NIKKOL under the reference LECINOL S 10.
  • the hydrogenated lecithin is present at a concentration between 0.05% and 5% by weight with respect to the total weight of the composition, preferably between 0.08% and 4% by weight, preferably between 0.1% and 3% by weight, preferably between 0.2% and 2% by weight, preferably between 0.3% and 1% by weight, advantageously between 0.4% and 0.8% by weight.
  • composition according to the invention comprises at least one thickener chosen from acrylic polymers and acrylamide polymers.
  • Acrylic polymer means a polymer obtained from at least one (meth)acrylic acid monomer.
  • Acrylamide polymer means a polymer obtained from at least one monomer comprising an acrylamide function, optionally substituted.
  • the acrylic polymer is chosen from homopolymers and copolymers based on acrylamido methylpropane sulfonic acid or one of its salts.
  • the thickener is chosen from:
  • AMPS® acrylamido methylpropane sulfonic acid
  • Lubrizol monomer acrylamido methylpropane sulfonic acid
  • salts such as for example:
  • the thickener is chosen from copolymers of (meth)acrylic acid and C10- C30 alkyl acrylate, copolymers based on acrylamido methylpropane sulfonic acid or one of its salts, and any of the mixtures thereof.
  • the thickener is a mixture of at least one copolymer of (meth)acrylic copolymer and C10-C30 alkyl acrylate and at least one copolymer based on acrylamido methylpropane sulfonic acid or one of its salts, advantageously is a mixture of a copolymer of acrylic acetate and C10-C30 alkyl acrylate and a copolymer of ammonium acrylamido methylpropane sulfonate and vinylpyrrolidone.
  • the thickener is present at a concentration between 0.1 % and 10% by weight with respect to the total weight of the composition, preferably between 0.3% and 5% by weight, preferably between 0.5% and 3% by weight, preferably between 0.8% and 2% by weight, preferably between 1.0% and 1.5% by weight, advantageously between 1.1% and 1.5% by weight.
  • the composition of the invention is substantially free from xanthan gum.
  • “Substantially free from xanthan gum” means that the composition comprises less than 1 % by weight with respect to the total weight of the composition, preferably less than 0.5% by weight, preferably less than 0.3% by weight, preferably less than 0.1% by weight, more preferably from 0.01 % to 1 % by weight of xanthan gum. Preferably, the composition is totally free from xanthan gum.
  • the composition according to the invention is substantially free from polysaccharide biopolymers, such as xanthan gum, guar gum, gum arabic, locust bean gum, acacia gum, scleroglucans, chitin derivatives and chitosan derivatives, carrageenans, gellans, alginates, or celluloses such as microcrystalline cellulose, carboxymethylcellulose, hydroxymethylcellulose, hydroxyethylcellulose and hydroxypropylcellulose.
  • polysaccharide biopolymers such as xanthan gum, guar gum, gum arabic, locust bean gum, acacia gum, scleroglucans, chitin derivatives and chitosan derivatives, carrageenans, gellans, alginates, or celluloses such as microcrystalline cellulose, carboxymethylcellulose, hydroxymethylcellulose, hydroxyethylcellulose and hydroxypropylcellulose.
  • Substantially free from polysaccharide biopolymers means that the composition comprises less than 1% by weight with respect to the total weight of the composition, preferably less than 0.5% by weight, preferably less than 0.3% by weight, preferably less than 0.1 % by weight, more preferably from 0.01% to 1 % by weight of polysaccharide biopolymers. Preferably, the composition is totally free from polysaccharide biopolymers. c) Lauroyl lysine and its salts
  • composition according to the invention comprises lauroyl lysine or one of its salts.
  • Lauroyl lysine denotes the compound of the following formula:
  • lauroyl lysine has for example the following formula:
  • Lauroyl lysine is obtained by reacting lauric acid and lysine. It is an ingredient of interest for the formulation of cosmetic products such as makeup or care products. This compound is typically presented in powder form. Lauroyl lysine or one of its salts is generally used as a filler and/or non-colorant base.
  • Lauroyl lysine is for example marketed under the name AMIHOPE LL by Ajinomoto.
  • lauroyl lysine or one of its salts is present at a concentration between 0.05% and 5% by weight with respect to the total weight of the composition, preferably between 0.08% and 4% by weight, preferably between 0.1 % and 3% by weight, preferably between 0.2% and 2% by weight, preferably between 0.3% and 1 % by weight, advantageously between 0.4% and 0.8% by weight.
  • Isopropyl isostearate is present at a concentration between 0.05% and 5% by weight with respect to the total weight of the composition, preferably between 0.08% and 4% by weight, preferably between 0.1 % and 3% by weight, preferably between 0.2% and 2% by weight, preferably between 0.3% and 1 % by weight, advantageously between 0.4% and 0.8% by weight.
  • composition according to the invention comprises isopropyl isostearate, of the following formula:
  • isopropyl isostearate is present at a concentration between 0.5% and 20% by weight with respect to the total weight of the composition, preferably between 1 % and 15% by weight, preferably between 2% and 10% by weight, preferably between 3% and 8% by weight, preferably between 4% and 6% by weight, advantageously between 4.5% and 5% by weight.
  • the composition according to the invention comprises an oily phase, in particular in the form of an oil.
  • Oil denotes any fatty substance in liquid form at ambient temperature (20 - 25°C) and at atmospheric pressure (760 mm Hg) .
  • the oil is a non-volatile oil.
  • non-volatile oil denotes an oil remaining on skin or keratin fiber at ambient temperature and atmospheric pressure for at least several hours and particularly having a vapor pressure less than 10 -3 mm Hg (0.13 Pa).
  • non-volatile, non-hydrocarbon oils that can be used, mention may be made in particular of: (i) hydrocarbon oils of plant origin such as triglyceride esters that are generally triesters of fatty acids and glycerol with chain lengths ranging from C4 to C24, with the latter optionally being linear or branched, saturated or unsaturated; these oils are in particular wheat germ, sunflower, grape seed, sesame, corn, apricot, castor, jojoba, shea, avocado, olive, soybean oils, almond and particularly sweet almond, palm, rapeseed, cotton, hazelnut, macadamia, alfalfa, poppy seed, pumpkin, sesame, squash, rapeseed, blackcurrant, evening primrose, millet, barley, quinoa, rye, safflower, candlenut, passiflora, musk rose, coconut oils; or capryl ic/capric acid triglycerides such as those sold by Stearineries Du
  • synthetic ethers for example linear or branched dialkyl ethers, symmetrical or non-symmetrical, containing 6 to 22 carbon atoms per alkyl group, such as dicaprylyl ether (Cetiol® OE);
  • linear or branched hydrocarbons of mineral or synthetic origin such as petrolatum oil, polydecenes, hydrogenated polyisobutene such as Parleam, squalane, and mixtures thereof (inorganic oils);
  • fatty amides such as isopropyl N-lauroyl sarcosinate like the product sold under the trade name Eldew SL 205® by Ajinomoto and mixtures thereof.
  • the composition comprises from 0.005% to 15% by weight of oily phase with respect to the total weight of the composition, more preferably from 0.01 % to 10% by weight, even more preferably from 1% to 9% by weight.
  • the composition according to the invention comprises, with respect to the total weight of the composition, less than 4% by weight, preferably less than 3% by weight, preferably less than 2% by weight, preferably from 0.01 to 4% by weight, of hydrocarbon oil of plant origin.
  • the composition is substantially free from jojoba oil.
  • Substantially free from jojoba oil means that the composition comprises less than 2% by weight with respect to the total weight of the composition, preferably less than 1% by weight, preferably less than 0.3% by weight, preferably less than 0.1 % by weight, more preferably from 0.01% to 2% by weight of jojoba oil. Preferably, the composition is totally free from jojoba oil.
  • composition according to the invention comprises an aqueous phase.
  • An aqueous phase contains water, and optionally at least one organic solvent that is soluble or miscible in water.
  • the water used may be sterile demineralized water and/or floral water such as rose water, cornflower water, chamomile water or linden water, and/or a spring or natural mineral water, such as for example: Vittel water, water from the basin of Vichy, Uriage water, la Roche Posay water, la Bourboule water, Enghien-les-Bains water, Saint Gervais-les-Bains water, Neris-les-Bains water, Allevar-les-Bains water, Digne water, Maizieres water, Neyrac-les-Bains water, Lons-le-Saunier water, les Eaux Bonnes, Rochefort water, Saint Christau water, Fumades water and Tercis-les-bains water, Avene water.
  • floral water such as rose water, cornflower water, chamomile water or linden water
  • a spring or natural mineral water such as for example: Vittel water, water from the basin of Vichy, Uriage water, la Roche Posay water, la Bourboule water
  • the aqueous phase can also comprise at least one organic solvent miscible in water, at 25°C.
  • the water-miscible organic solvent is chosen from alcohols, polyols and mixtures thereof.
  • alcohols mention may be made of C1-C10, more preferably C1-C5, alcohols, such as ethanol, isopropanol, propanol and butanol.
  • the polyol is, preferably, chosen from polyols having from 2 to 20 carbon atoms, preferably from 2 to 10 carbon atoms, such as glycerol, diglycerol, propyleneglycol, isoprene glycol, dipropyleneglycol, butylene glycol, hexylene glycol, 1 ,2-propanediol, 1 ,3- propanediol, 1 ,5-pentanediol, pentylene glycol, 1 ,2-octanediol (caprylyl glycol), polyethyleneglycols having from 2 to 200 ethylene oxide units and mixtures thereof.
  • polyols having from 2 to 20 carbon atoms, preferably from 2 to 10 carbon atoms, such as glycerol, diglycerol, propyleneglycol, isoprene glycol, dipropyleneglycol, butylene glycol, hexylene glycol, 1 ,2-propan
  • the composition preferably comprises at least 50% by weight of water with respect to the total weight of the composition, preferably at least 60% by weight.
  • the composition preferably comprises 50% to 90% by weight of water with respect to the total weight of the composition, more preferably from 60% to 89% by weight.
  • the composition comprises from 1% to 20% by weight of water-miscible organic solvent, with respect to the total weight of the composition, more preferably from 5% to 15% by weight.
  • composition according to the invention may further comprise at least one surfactant, preferably non-ionic.
  • non-ionic surfactants mention can be made in particular of:
  • - oxyethylenated and/or oxypropylenated ethers that may include from 1 to 150 oxyethylenated and/or oxypropylenated groups) of glycerol;
  • - oxyethylenated and/or oxypropylenated ethers that may include from 1 to 150 oxyethylenated and/or oxypropylenated groups) of fatty alcohols (particularly C8-C24 and preferably C12-C18 alcohols) such as oxyethylenated ether of cetearyl alcohol with 30 oxyethylenated groups (CTFA name "Ceteareth-30”), oxyethylenated ether of stearyl alcohol with 20 oxyethylenated groups (CTFA name "Steareth-20”), oxyethylenated ether of the mix of C12-C15 fatty alcohols containing 7 oxyethylenated groups (CTFA name "C12- 15 Pareth-7”) marketed particularly under the trade name NEODOL 25-7® by SHELL CHEMICALS;
  • fatty alcohols particularly C8-C24 and preferably C12-C18 alcohols
  • esters of fatty acids particularly C8-C24 acid and preferably C16-C22 acid
  • polyol in particular of glycerol or of sorbitol, such as glyceryl stearate, such as the product sold under the trade name TEGIN M® by GOLDSCHMIDT, glyceryl laurate such as the product sold under the trade name IMWITOR 312® by HULS, polyglyceryl-2 stearate, sorbitan tristearate, glyceryl ricinoleate;
  • esters for example monoesters, diesters or triesters, preferably monoesters, of fatty acid (in particular C8-C24, and preferably C10-C20 acid) and of polyglycerol comprising from 1 to 12 glycerol units, preferably from 2 to 10 glycerol units, for example polyglyceryl-4 caprate and polyglyceryl-2 oleate;
  • polyethylene oxide which are preferably those in which the number of ethylene oxide (EG) units varies from 2 to 200.
  • EG ethylene oxide
  • esters of polyoxyalkylenated fatty acids for example PEG-60 hydrogenated castor oil, optionally in association with an ester of fatty acid and glycerol such as the PEG-100 Stearate/Glyceryl Stearate mixture marketed for example by Croda under the trade name Arlacel 165®;
  • esters or mixtures of esters of fatty acid and sucrose, maltose, glucose or fructose for example sucrose monostearate, sucrose distearate and sucrose tristearate and mixtures thereof, such as the products sold by Croda under the name Crodesta F50, F70, F110 and F160®;
  • fatty acid esters particularly C8-C24 acid, and preferably C16-C22 acid
  • oxyethylenated and/or oxypropylenated glycerol ethers that may include 1 to 150 oxyethylenated and/or oxypropylenated groups
  • PEG-200 glyceryl monostearate sold particularly under the trade name Simulsol 220 TM® by SEPPIC
  • PEG-50 stearate and PEG-40 monostearate marketed particularly under the name MYRJ 52P® by ICI UNIQUEMA
  • polyethoxylated glyceryl stearate with 30 ethylene oxide groups such as the product TAGAT S® sold by Evonik GOLDSCHMIDT, polyethoxylated glyceryl oleate with 30 ethylene oxide groups such as the product TAGAT O® sold by Evonik GOLDSCHMIDT, polyethoxylated glyceryl cocoate with 30 ethylene oxide groups such as the product
  • - fatty acid esters particularly C8-C24 acid and preferably C16-C22 acid
  • oxyethylenated and/or oxypropylenated sorbitol ethers that may include 1 to 150 oxyethylenated and/or oxypropylenated groups
  • polysorbate 20 particularly sold under the trade name Tween 20® by CRODA
  • polysorbate 60 particularly sold under the trade name Tween 60® by CRODA
  • mixtures thereof such as polysorbate 20 particularly sold under the trade name Tween 20® by CRODA, polysorbate 60 particularly sold under the trade name Tween 60® by CRODA, and mixtures thereof.
  • the composition may contain one or more of the usual active agents or excipients in the cosmetic and dermatological fields, such as hydrating agents; emollients; active agents; antioxidants; perfumes; film-forming agents; dyestuffs; sequestering agents; electrolytes; pH adjusters; fillers; preservatives; antioxidants; plant extracts and mixtures thereof.
  • active agents or excipients such as hydrating agents; emollients; active agents; antioxidants; perfumes; film-forming agents; dyestuffs; sequestering agents; electrolytes; pH adjusters; fillers; preservatives; antioxidants; plant extracts and mixtures thereof.
  • the quantities of these different excipients are those conventionally used in the fields in question. In particular, these quantities vary according to the sought purpose and can for example range from 0.01% to 20%, and preferably from 0.1 % to 10% by weight of the total weight of the composition.
  • the composition is substantially free from perlite.
  • “Substantially free from perlite” means that the composition comprises less than 1% by weight with respect to the total weight of the composition, preferably less than 0.5% by weight, preferably less than 0.3% by weight, preferably less than 0.1% by weight, more preferably from 0.01% to 1 % by weight of perlite. Preferably, the composition is totally free from perlite.
  • composition according to the invention may be obtained conventionally by those skilled in the art.
  • the present invention also relates to a cosmetic method for the care of keratin materials, preferably the skin, comprising the application of a composition according to the invention on said keratin materials.
  • Example 1 Preparation of the composition according to the invention C2 and comparative compositions C1 *, C3*, and C4*
  • composition according to the invention C2 and comparative compositions C1 *, C3* and C4* are prepared with the ingredients mentioned in the table hereinbelow, according to the following protocol:
  • the oily phase containing the surfactants is heated to 75°C, then the aqueous phase is incorporated slowly, and the cooling is started.
  • the polymers are dispersed and then neutralized.
  • the active agents, then the fillers, then the alcohol are then added in steps and then dispersed, at ambient temperature, until a homogeneous mixture is obtained.
  • the quantities of each ingredient are expressed as a mass ratio with to the total weight of the composition.
  • Example 2 Evaluation of the composition according to the invention C2 and comparative compositions C1 *, C3*, and C4*
  • composition according to the invention C2 and comparative compositions C1 *, C3* and C4* were tested by a panel of testers, who were requested to evaluate six parameters using 11 -point rating scales ranging from 0 to 10.
  • composition C2 comprising lauroyl lysine and isopropyl isostearate, makes it possible to obtain a composition free from silicone but providing virtually identical sensory properties to composition C1 * comprising silicones.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)

Abstract

La présente invention concerne une composition, de préférence cosmétique, comprenant, dans un milieu physiologiquement acceptable : a) de la lécithine hydrogénée, b) au moins un épaississant choisi parmi les polymères acryliques et les polymères d'acrylamide, c) la lauroyl lysine ou l'un de ses sels, et d) l'isostéarate d'isopropyle, ladite composition étant sensiblement exempte de silicone.
PCT/EP2024/071577 2023-07-31 2024-07-30 Composition de soin sans silicone pour matières kératiniques Pending WO2025027033A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FRFR2308273 2023-07-31
FR2308273A FR3151762A1 (fr) 2023-07-31 2023-07-31 Composition de soin sans silicone pour les matières kératiniques

Publications (1)

Publication Number Publication Date
WO2025027033A1 true WO2025027033A1 (fr) 2025-02-06

Family

ID=88585147

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2024/071577 Pending WO2025027033A1 (fr) 2023-07-31 2024-07-30 Composition de soin sans silicone pour matières kératiniques

Country Status (2)

Country Link
FR (1) FR3151762A1 (fr)
WO (1) WO2025027033A1 (fr)

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE GNPD [online] MINTEL; 2 June 2023 (2023-06-02), ANONYMOUS: "Milk Tint SPF 43 Broad Spectrum Tinted Primer Serum", XP093124825, retrieved from https://www.gnpd.com/sinatra/recordpage/10776036/ Database accession no. 10776036 *
DATABASE GNPD [online] MINTEL; 31 August 2023 (2023-08-31), ANONYMOUS: "Cream", XP093124821, retrieved from https://www.gnpd.com/sinatra/recordpage/11010156/ Database accession no. 11010156 *
DATABASE GNPD [online] MINTEL; 6 August 2015 (2015-08-06), ANONYMOUS: "Intensive Cream", XP093124724, retrieved from https://www.gnpd.com/sinatra/recordpage/3384369/ Database accession no. 3384369 *

Also Published As

Publication number Publication date
FR3151762A1 (fr) 2025-02-07

Similar Documents

Publication Publication Date Title
US10092492B2 (en) Cosmetic composition comprising spiculisporic acid and at least one surfactant
WO2019245011A1 (fr) Composition acide stable
WO2025027033A1 (fr) Composition de soin sans silicone pour matières kératiniques
WO2017070940A1 (fr) COMPOSITION AYANT UNE PHASE α-CRISTALLINE
CN105307626B (zh) 预防或减少皮肤色素沉着并且淡化肤色的组合物及其用途
US12036304B2 (en) Low viscosity emulsion cosmetic composition
WO2023275743A1 (fr) Composition cosmétique en émulsion à faible viscosité
CN114727911B (zh) 用于局部施用的两相组合物
WO2021134454A1 (fr) Composition pour produits cosmétiques
JP7429316B1 (ja) ポリグリセリン脂肪酸エステル
US11642293B2 (en) Composition for caring for skin, method and use thereof
US20250064714A1 (en) Cosmetic composition including ethoxylated materials to improve physical stability of polymeric emulsions
CN105307729A (zh) 用于预防或减少皮肤色素沉着和/或淡化肤色的局部组合物及其用途
WO2025046336A1 (fr) Composition cosmétique comprenant des matériaux éthoxylés pour améliorer la stabilité physique d'émulsions polymères
US11540982B2 (en) Demake-up micellar milk
WO2022021329A1 (fr) Composition de soin de matières kératiniques et son procédé d'utilisation
US20230270634A1 (en) Gel cream emulsion cosmetic composition with high salt actives
WO2023161706A1 (fr) Composition cosmétique gel-crème-émulsion avec principes actifs à haute teneur en sel
WO2023118167A1 (fr) Composition cosmétique contenant une combinaison de vanilline ou d'un de ses dérivés, d'alcool aromatique et de monoalcool aliphatique
EP3558215B1 (fr) Composition présentant une phase alpha-cristalline
WO2022208394A1 (fr) Agent démaquillant anti-bavures multiphase à base d'eau
EP1534234B1 (fr) Composition et son utilisation comme formulation pharmaceutique ou cosmetique pour une application externe
WO2016180979A1 (fr) Composition comportant des dérivés d'acide salicylique et un solvant particulier

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 24746374

Country of ref document: EP

Kind code of ref document: A1